Sort
39,280 grants matching “leukemia”
Role of Runx1 in Pathologic Ocular Angiogenesis
$528,075Leo A Kim · Schepens Eye Research Institute · R01 · FY2021 · EY
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia
$528,062Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$528,033Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2023 · CA
Therapeutic targeting of IRAK4 in MDS
$528,024Amit Verma · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Targeting gasdermin D to treat myelodysplastic syndromes
$527,987Peng Ji · Northwestern University At Chicago · R01 · FY2024 · HL
Therapeutic targeting of growth factor receptors to treat Mucormycosis
$527,986Vincent Michael Bruno · University Of Maryland Baltimore · R01 · FY2019 · AI
Genomics of AML: Contribution of Cytokine Signaling Pathways to Leukemogenesis
$527,901Michael H Tomasson · Washington University · P01 · FY2011 · CA
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
$527,877John C Byrd · Ohio State University · R01 · FY2015 · CA
Inflammation, Macrophage Differentiation, and Cancer
$527,854Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$527,849University Of Illinois At Chicago · U10 · FY2002 · CA
Predictors of Adult Leukemia
$527,845University Of Minnesota Twin Cities · R01 · FY2005 · CA
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
$527,781Richard A. Van Etten · University Of California-Irvine · R01 · FY2019 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$527,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Development of VN/14-1 and Related Analogs for Breast Cancer Therapy
$527,599Vincent Collins Ofuka Njar · Thomas Jefferson University · R01 · FY2011 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2022 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2025 · CA
Targeted Therapies for Lymphoid Malignancies
$527,476Jennifer A. Woyach · Ohio State University · R01 · FY2023 · CA
Targeted Therapies for Lymphoid Malignancies
$527,476Jennifer A. Woyach · Ohio State University · R01 · FY2022 · CA
(PQC2) Localization as a determinant of cancer dormancy
$527,391Charles P Lin · Massachusetts General Hospital · R01 · FY2016 · CA
VCU Minority-Based CCOP
$527,332John D Roberts · Virginia Commonwealth University · U10 · FY2007 · CA
Novel Targeted Anticancer Agents from Marine Cyanobacteria
$527,273Hendrik Luesch · University Of Florida · R01 · FY2025 · CA
ROLE OF UBIQUITIM-LIKE PROTEINS IN DICTYOSTELIU
$527,178Columbia University Health Sciences · R01 · FY2002 · GM
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$527,013University Of Virginia Charlottesville · R37 · FY2000 · AI
Pre- and Postgraduate training in Molecular Hematology
$526,917J Evan Sadler · Washington University · T32 · FY2013 · HL
Aim 4: Target discovery for common disease mechanisms
$526,812Peter Karl Sorger · Harvard Medical School · P50 · FY2015 · GM